insights_auto
Bakit bumaba ang ANW 6.06%?
Tingnan ang Higit pang Detalyechevron_right
ANW:FRA
Immuron Ltd
€0.016
arrow_downward
-6.06%(-0.0010) 1D
Okt 16, 8:02:11 AM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ANW...
Buksan
€0.02
Mataas
€0.02
Mababa
€0.02
Mkt. cap
8.97M
Avg. na dami
904.00
Dami
0.00
Mataas nang 52-wk
€0.04
Mababa nang 52-wk
€0.01
Bilang ng mga empleyado
8
Buksan
€0.02
Mataas
€0.02
Mababa
€0.02
Mkt. cap
8.97M
Avg. na dami
904.00
Dami
0.00
Mataas nang 52-wk
€0.04
Mababa nang 52-wk
€0.01
Bilang ng mga empleyado
8
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Stock Titan
·
2 oras ang nakalipas
Shareholders will vote on a 12.5% rolling three-year stock incentive cap at Immuron (IMRN).
Stock Titan
·
3 araw ang nakalipas
A travel-diarrhea pill showed 50% less severe diarrhea, but missed its main trial goals
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Tungkol sa Immuron Ltd
CEO-
Mga Empleyado8
Itinatag1994
HeadquartersBlackburn North, Victoria, Australia
Sektor-
Websiteimmuron.com.au